In this report, the authors present the first case of adult brainstem pilocytic astrocytoma (PA) with the H3 K27M mutation. A 53-year-old man was incidentally found to have a 2.5-cm partially enhanced tumor in the tectum on MRI. The enhancement in the lesion increased over 3 years, and gross-total removal was performed via the occipital transtentorial approach. The resected tissue indicated PA, WHO Grade I, and genetic analysis revealed the H3 K27M mutation. However, although the radiological, surgical, and pathological findings all corresponded to PA, this entity can easily be misdiagnosed as diffuse midline glioma with the H3 K27M mutation, which is classified as a WHO Grade IV tumor according to the updated classification. This case highlights the phenotypic spectrum of PA, as well as the biology of the H3 K27M–mutated gliomas, and may prove to be an exception to the rule that diffuse midline gliomas with the H3 K27M mutation behave in an aggressive manner. Based on the findings of this case, the authors conclude that, in addition to detecting the existence of the H3 K27M mutation, an integrated approach in which a combination of clinical, pathological, and genetic information is used should be applied for accurate diagnosis and determination of the appropriate treatment for diffuse midline gliomas.
Correspondence Masayuki Nitta, Department of Neurosurgery, Tokyo Women’s Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo 162-8666, Japan. email: firstname.lastname@example.org.INCLUDE WHEN CITING Published online September 29, 2017; DOI: 10.3171/2017.4.JNS162443.Disclosures The authors report no conflict of interest concerning the materials or methods used in this study or the findings specified in this paper.
BechetDGielenGGKorshunovAPfisterSMRoussoCFauryD: Specific detection of methionine 27 mutation in histone 3 variants (H3K27M) in fixed tissue from high-grade astrocytomas. Acta Neuropathol128:733–7412014
BurkhardC, Di PatrePL, SchülerD, SchülerG, YaşargilMG, YonekawaY, : A population-based study of the incidence and survival rates in patients with pilocytic astrocytoma. 98:1170–1174, 200310.3171/jns.2003.98.6.117012816259)| false
JansenMHVeldhuijzen van ZantenSESanchez AliagaEHeymansMWWarmuth-MetzMHargraveD: Survival prediction model of children with diffuse intrinsic pontine glioma based on clinical and radiological criteria. Neuro Oncol17:160–1662015
JansenMH, Veldhuijzen van ZantenSE, Sanchez AliagaE, HeymansMW, Warmuth-MetzM, HargraveD, : Survival prediction model of children with diffuse intrinsic pontine glioma based on clinical and radiological criteria. 17:160–166, 201510.1093/neuonc/nou10424903904)| false
JohnsonDRBrownPDGalanisEHammackJE: Pilocytic astrocytoma survival in adults: analysis of the Surveillance, Epidemiology, and End Results Program of the National Cancer Institute. J Neurooncol108:187–1932012
JohnsonDR, BrownPD, GalanisE, HammackJE: Pilocytic astrocytoma survival in adults: analysis of the Surveillance, Epidemiology, and End Results Program of the National Cancer Institute. 108:187–193, 201210.1007/s11060-012-0829-022367412)| false
LouisDNPerryABurgerPEllisonDWReifenbergerGvon DeimlingA: International Society Of Neuropathology-Haarlem consensus guidelines for nervous system tumor classification and grading. Brain Pathol24:429–4352014
LouisDN, PerryA, BurgerP, EllisonDW, ReifenbergerG, von DeimlingA, : International Society Of Neuropathology-Haarlem consensus guidelines for nervous system tumor classification and grading. 24:429–435, 201410.1111/bpa.12171)| false
LouisDNPerryAReifenbergerGvon DeimlingAFigarella-BrangerDCaveneeWK: The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol131:803–8202016
LouisDN, PerryA, ReifenbergerG, von DeimlingA, Figarella-BrangerD, CaveneeWK, : The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. 131:803–820, 20162715793110.1007/s00401-016-1545-1)| false
ShioyamaTMuragakiYMaruyamaTKomoriTIsekiH: Intraoperative flow cytometry analysis of glioma tissue for rapid determination of tumor presence and its histopathological grade: clinical article. J Neurosurg118:1232–12382013